CLOFARABINE is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Fresenius-kabi. The primary component is Clofarabine.
| Product ID | 63323-572_171fac5c-1ab6-47d5-87d5-d23171f33cbd |
| NDC | 63323-572 |
| Product Type | Human Prescription Drug |
| Proprietary Name | CLOFARABINE |
| Generic Name | Clofarabine |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2017-05-10 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA204029 |
| Labeler Name | Fresenius-Kabi |
| Substance Name | CLOFARABINE |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2017-05-10 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA204029 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-05-10 |
| Ingredient | Strength |
|---|---|
| CLOFARABINE | 1 mg/mL |
| SPL SET ID: | fe6ff0f9-7610-4a69-9b75-da7ec4bb7744 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0955-1746 | clofarabine | clofarabine |
| 43598-309 | Clofarabine | Clofarabine |
| 49315-003 | CLOFARABINE | clofarabine |
| 50742-512 | CLOFARABINE | clofarabine |
| 55150-326 | CLOFARABINE | CLOFARABINE |
| 60505-6166 | Clofarabine | clofarabine |
| 63323-572 | CLOFARABINE | clofarabine |
| 67457-546 | clofarabine | clofarabine |
| 68083-386 | Clofarabine | Clofarabine |
| 70121-1236 | Clofarabine | Clofarabine |
| 71288-128 | Clofarabine | Clofarabine |
| 72266-108 | CLOFARABINE | CLOFARABINE |
| 0024-5860 | Clolar | clofarabine |
| 0024-5917 | Clolar | clofarabine |